The role of the rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway as the main RAS effector pathway in initiation and progression of pancreatic cancer is well established [3]. The gene discussed is RAF1; the disease is familial pancreatic carcinoma.